HBRM Stock - Herborium Group, Inc.
Unlock GoAI Insights for HBRM
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.05M | $1.12M | $1.13M | $1.05M | $993,500 |
| Gross Profit | $662,000 | $624,345 | $702,200 | $662,000 | $639,200 |
| Gross Margin | 63.0% | 55.8% | 62.0% | 63.0% | 64.3% |
| Operating Income | $-287,500 | $28,720 | $-267,040 | $-287,500 | $68,700 |
| Net Income | $-328,770 | $29,523 | $-267,040 | $-328,770 | $47,100 |
| Net Margin | -31.3% | 2.6% | -23.6% | -31.3% | 4.7% |
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. It offers dermatology products, which include AcnEase, herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars. The company also provides sexual health and performance products that are non-prescriptive alternatives to selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, and surgical procedures, including hysterectomy. In addition, it offers energy restoration products, such as Lasting Energy, a herbal supplement to decrease the symptoms associated with hangovers and eliminating jet-lag; and for treating overall depletion of energy due to competitive sports, high levels of stress, and extensive sexual activities, as well as other long term or temporary physical demands. Further, the company provides Liver Activator Series for the treatment of liver damage; ProstAid, a natural product focuses on Benign Prostate Hyperplasia; and CardioVitae, a fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies. Herborium Group, Inc. sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. The company was founded in 2000 and is headquartered in Fort Lee, New Jersey.
Visit WebsiteEarnings History & Surprises
HBRMEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2024 | Jul 10, 2024 | — | — | — | — |
Q2 2024 | Apr 18, 2024 | — | — | — | — |
Q1 2024 | Feb 15, 2024 | — | — | — | — |
Q4 2023 | Dec 28, 2023 | — | — | — | — |
Q3 2023 | Jul 15, 2023 | — | — | — | — |
Q2 2023 | Apr 17, 2023 | — | — | — | — |
Q3 2022 | Jul 21, 2022 | — | — | — | — |
Q2 2022 | Apr 25, 2022 | — | — | — | — |
Q3 2008 | Aug 31, 2008 | — | $-2.21 | — | — |
Q2 2008 | May 31, 2008 | — | $-2.25 | — | — |
Q1 2008 | Feb 29, 2008 | — | $-1.36 | — | — |
Q4 2007 | Nov 30, 2007 | — | $-1.42 | — | — |
Q3 2007 | Aug 31, 2007 | — | $-1.43 | — | — |
Q2 2007 | May 31, 2007 | — | $-1.25 | — | — |
Q1 2007 | Feb 28, 2007 | — | $-0.86 | — | — |
Q4 2006 | Nov 30, 2006 | — | $-0.78 | — | — |
Q3 2006 | Aug 31, 2006 | — | $-0.49 | — | — |
Q2 2005 | Jun 30, 2005 | — | $-64.16 | — | — |
Q1 2005 | Mar 31, 2005 | — | $-95.98 | — | — |
Q4 2004 | Dec 31, 2004 | — | $-45.12 | — | — |
Latest News
Frequently Asked Questions about HBRM
What is HBRM's current stock price?
What is the analyst price target for HBRM?
What sector is Herborium Group, Inc. in?
What is HBRM's market cap?
Does HBRM pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to HBRM for comparison